Q2
SCI-Expanded Hakemli
‘‘A National, Multiticenter, Secondary Data Use Study Evaluating Efficacy and Retention of First‑line Biologic Treatment with Tocilizumab in Patients with Rheumatoid Arthritis in Real‑life Setting:…
Scientific Reports · 2022 · Cilt 12